38 Reduction of activity of Arylsulfatasi B in patient with Cystic Fibrosis  by Pagliardini, S. et al.
2. CFTR – Cell biology/Physiology S9
38 Reduction of activity of Arylsulfatasi B in patient with Cystic Fibrosis
S. Pagliardini2, A. Veljkovic1, I. Tardivo1, M.P. Forneris1, C. Bena2, G.B. Ferrero2,
E. Bignamini1. 1Pediatric Cystic Fibrosis Center, A.O. OIRM-Sant’Anna, Turin, Italy;
2Dep. of Pediatric Sciences, University of Turin, Turin, Italy
Arylsulfatase B (ArylB) is a lisosomal enzyme responsible for degradation of
condroitin-4-sulfate (C4S) and dermatan sulphate (DS). Accumulation of C4S and
DS has been observed in patients with Cystic Fibrosis (CF).
The purpose of our study was to evaluate enzymatic lisosomal activities, Aryl B and
a-Galactosidase A (a-Gal), in group of paediatric CF patients compare with a control
group.
238 children were tested. For Aryl B analysis was used a test according to the
technique of Christomauon and Sandhoff, adapted on spot and having as substrate
4-methylumbelliferyl sulphate and for a-Gal was used a test according to the tech-
nique of Kint, adapted on spot and having as substrate 4-methylumbelliferyl-a-D-
galactopyranoside. Enzymatic activity has been corrected by the number of leukocytes.
The results ware statistically elaborated using linear regression considering difference
in sex and age (STATA 9.1®).
Patients with CF showed a signiﬁcant reduction of mean activity of Aryl B for
1.22NM/h/ml of whole blood (p< 0.05; 95%CI 1.10−1.36). The mean a-Gal resulted
increase for 0.73NM/h/ml of whole blood in FC patients (p< 0.05; 95%CI 0.64−0.83).
Groups Nº M F age yrs
CF 57 26 31 6.82
Controls 181 103 78 6.42
Conclusions: This study shows that CF patients have a reduced mean activity of Aryl
B, and an increased mean activity of a-Gal. A generalized reduction of lisosomal
enzymatic activities is not conﬁrmed by these data. The cause and the role of selective
Aryl B enzymatic reduction remains to be elucidated, being an intriguing putative
metabolic disturbance playing a role in the pathogenesis of CF.
